Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 76–90 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2796
ADNP Gene Helsmoortel-van der Aa Syndrome Genetic Test

This genetic test identifies pathogenic variants in the ADNP gene, confirming Helsmoortel-van der Aa syndrome.

Whole blood (EDTA) or DNA FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ADNP gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants"]
Parameters
[]
Preparation
[]
Indications
["Infants and children with suspected Helsmoortel-van der Aa syndrome", "Patients presenting with clinical features suggestive of ADNP-related neurodevelopmental disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81305-5 ICD-10: Q87.89
Clinical summary
This genetic test identifies pathogenic variants in the ADNP gene, confirming Helsmoortel-van der Aa syndrome.
TEST-117
ADRB2 Genotyping for Beta‑2 Agonist Responsiveness Test

This test evaluates genetic variations in the ADRB2 gene to predict responsiveness to beta-2 agonist bronchodilators.

Peripheral Whole Blood (EDTA lavender-top tube) 10 working days 750.00 AED
View
View test specifications and preparation
What it measures
["ADRB2 gene variants (e.g., Arg16Gly, Gln27Glu)", "Predicted response to beta-2 agonists"]
Parameters
[]
Preparation
["No special preparation required", "Continue all medications as prescribed"]
Indications
["Optimising beta-2 agonist therapy", "Personalised management of asthma", "Personalised management of COPD"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: J45.9
Clinical summary
This test evaluates genetic variations in the ADRB2 gene to predict responsiveness to beta-2 agonist bronchodilators.
TEST-4581
AFF3 Gene Rheumatoid Arthritis Susceptibility Genetic Test

This test evaluates for specific genetic variants within the AFF3 gene associated with an increased risk of developing rheumatoid arthritis.

Peripheral Whole Blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AFF3 gene variants", "Genetic susceptibility to rheumatoid arthritis"]
Parameters
[]
Preparation
[]
Indications
["Individuals with a family history of rheumatoid arthritis or other autoimmune diseases", "Individuals with first-degree relatives with known AFF3 variants", "Individuals seeking personalized insight into their autoimmune risk profile"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Z15.89, M06.9
Clinical summary
This test evaluates for specific genetic variants within the AFF3 gene associated with an increased risk of developing rheumatoid arthritis.
TEST-5711
AFG3L2 Gene Spastic Ataxia Type 5, Autosomal Recessive Genetic Test

This test identifies pathogenic variants in the AFG3L2 gene associated with autosomal recessive spastic ataxia type 5.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Biallelic pathogenic variants in the AFG3L2 gene"]
Parameters
[]
Preparation
["No special preparation such as fasting is required", "Mandatory pre-test genetic counselling session is needed"]
Indications
["Patients presenting with clinical signs of progressive spastic paraparesis and cerebellar atrophy on neuroimaging", "Family history suggestive of autosomal recessive spastic ataxia type 5"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81263-4 ICD-10: G11.8
Clinical summary
This test identifies pathogenic variants in the AFG3L2 gene associated with autosomal recessive spastic ataxia type 5.
TEST-6376
AGL Gene Glycogen Storage Disease Type 3 Genetic Test

This test identifies pathogenic variants in the AGL gene, confirming a diagnosis of Glycogen Storage Disease Type III (Cori Disease). It analyzes the entire coding region of the ge...

Whole blood (EDTA) – 3-5 mL 21 to 28 calendar days with interim verbal report at Day 14 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AGL gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications or dietary regimens without consulting a physician"]
Indications
["Suspected Glycogen Storage Disease Type III based on clinical presentation", "Biochemical evidence of glycogen debranching enzyme deficiency", "Family history of GSD Type III", "Carrier screening in at-risk individuals", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 89952-7 ICD-10: E74.03
Clinical summary
This test identifies pathogenic variants in the AGL gene, confirming a diagnosis of Glycogen Storage Disease Type III (Cori Disease). It analyzes the entire coding region of the gene using Next-Generation Sequencing.
TEST-6120
AGPAT2 Gene Lipodystrophy Generalized Type 1 Genetic Test

This genetic test analyzes the AGPAT2 gene to identify mutations causing congenital generalized lipodystrophy type 1 (CGL1). It provides a definitive molecular diagnosis for this r...

Peripheral whole blood (2–5 mL in EDTA tube) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Mutations in the AGPAT2 gene", "Coding region and flanking intronic boundaries"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "No specific fasting or medication adjustments required unless advised by physician"]
Indications
["Suspected congenital generalized lipodystrophy type 1 (CGL1)", "Family history of CGL1", "Need for definitive molecular diagnosis for management and family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82321-5 ICD-10: E88.1
Clinical summary
This genetic test analyzes the AGPAT2 gene to identify mutations causing congenital generalized lipodystrophy type 1 (CGL1). It provides a definitive molecular diagnosis for this rare metabolic disorder.
TEST-2386
AGPS Gene Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3) Genetic Test

This genetic test evaluates the AGPS gene for pathogenic variants associated with Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AGPS gene", "Single nucleotide variants", "Small indels", "Copy number variations"]
Parameters
[]
Preparation
["A detailed clinical history is required", "A genetic counselling session to draw a pedigree chart is required"]
Indications
["Suspected Rhizomelic Chondrodysplasia Punctata Type 3", "Family history of AGPS gene-related conditions", "Dysmorphology evaluation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48767-8 ICD-10: Q77.3
Clinical summary
This genetic test evaluates the AGPS gene for pathogenic variants associated with Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3).
TEST-3487
AGT Gene Renal Tubular Dysgenesis Genetic Test

This test identifies pathogenic variants in the AGT gene associated with autosomal recessive renal tubular dysgenesis.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AGT gene", "Coverage of coding exons, intronic boundaries, and promoter region"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy"]
Indications
["Suspected autosomal recessive renal tubular dysgenesis", "Family history of AGT-related disorders", "Prenatal diagnosis or preimplantation genetic testing (PGT) planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q60.4
Clinical summary
This test identifies pathogenic variants in the AGT gene associated with autosomal recessive renal tubular dysgenesis.
TEST-6218
AGXT Gene (Hyperoxaluria Type 1) Next-Generation Sequencing (NGS) Genetic Test

This test screens for pathogenic variants in the AGXT gene associated with primary hyperoxaluria type 1.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AGXT gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Confirmation of primary hyperoxaluria type 1 diagnosis", "Carrier screening in at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82931-7 ICD-10: E74.8, Z15.02, Z14.8
Clinical summary
This test screens for pathogenic variants in the AGXT gene associated with primary hyperoxaluria type 1.
TEST-2734
AHCY Gene Hypermethioninemia with S-Adenosylhomocysteine Hydrolase Deficiency Genetic Test

This genetic test identifies pathogenic variants within the AHCY gene, confirming or ruling out S-adenosylhomocysteine hydrolase deficiency.

Whole Blood (EDTA) or DNA FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AHCY gene", "Single nucleotide variants", "Small insertions", "Small deletions", "Copy number changes"]
Parameters
[]
Preparation
["No fasting or dietary modification required", "Inform team of blood-thinning medications", "Continue all prescribed treatments unless advised otherwise"]
Indications
["Suspected S-adenosylhomocysteine hydrolase deficiency", "Inborn errors of sulfur amino acid metabolism", "Family history of the disorder", "Asymptomatic siblings of confirmed cases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-5 ICD-10: E72.10
Clinical summary
This genetic test identifies pathogenic variants within the AHCY gene, confirming or ruling out S-adenosylhomocysteine hydrolase deficiency.
TEST-4928
AHDC1 Gene Genetic Test (Intellectual Disability, Autosomal Dominant Type 25 / MRD25)

This test sequences the AHDC1 gene to identify pathogenic variants responsible for Autosomal Dominant Intellectual Disability, Type 25 (MRD25). It is used for diagnosing neurodevel...

Peripheral whole blood (venous) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AHDC1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counselling session is mandatory"]
Indications
["Confirmation of clinical diagnosis for intellectual disability", "Guiding reproductive decision-making", "Investigating neurodevelopmental delay", "Identifying congenital anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96605-2 ICD-10: F70, Q87.8
Clinical summary
This test sequences the AHDC1 gene to identify pathogenic variants responsible for Autosomal Dominant Intellectual Disability, Type 25 (MRD25). It is used for diagnosing neurodevelopmental delay and congenital anomalies.
TEST-3845
AHNAK2 Gene Autism Spectrum Disorder NGS Test

This test evaluates the AHNAK2 gene for pathogenic variants associated with autism spectrum disorder susceptibility.

Whole Blood (Peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AHNAK2 gene"]
Parameters
[]
Preparation
["No specific fasting required"]
Indications
["Individuals with clinical features suggestive of Autism Spectrum Disorder", "Family history of Autism Spectrum Disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81321-9 ICD-10: F84.0
Clinical summary
This test evaluates the AHNAK2 gene for pathogenic variants associated with autism spectrum disorder susceptibility.
TEST-4909
AICDA Gene (Immunodeficiency with Hyper-IgM Type 2) Genetic Test

This test evaluates the AICDA gene for pathogenic variants associated with Hyper-IgM syndrome type 2, a primary immunodeficiency.

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AICDA gene", "Copy-number variants in the AICDA gene"]
Parameters
[]
Preparation
["Genetic counselling session required", "Provide complete clinical history", "Report bleeding disorders or anticoagulant use"]
Indications
["Suspected Hyper-IgM syndrome type 2", "Evaluation of primary immunodeficiency", "Genetic counseling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55176-5 ICD-10: D80.5
Clinical summary
This test evaluates the AICDA gene for pathogenic variants associated with Hyper-IgM syndrome type 2, a primary immunodeficiency.
TEST-4115
AIFM1 Gene (CMTX4) Genetic Test

This genetic test identifies pathogenic variants in the AIFM1 gene associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4).

Peripheral whole blood 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AIFM1 gene", "Coding region and intron-exon boundaries of AIFM1"]
Parameters
[]
Preparation
[]
Indications
["Individuals with suspected CMTX4", "Family members of individuals with CMTX4", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94893-5 ICD-10: G60.0
Clinical summary
This genetic test identifies pathogenic variants in the AIFM1 gene associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4).
TEST-6266
AIFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 6 Genetic Test

This genetic test identifies mutations in the AIFM1 gene associated with combined oxidative phosphorylation deficiency type 6.

Whole Blood (Peripheral) 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AIFM1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["Mandatory genetic counseling session required before testing", "No specific fasting or medication adjustments needed"]
Indications
["Suspected combined oxidative phosphorylation deficiency type 6", "Positive family history of mitochondrial disease", "Clinical presentation consistent with AIFM1-related disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92762-7 ICD-10: E88.4
Clinical summary
This genetic test identifies mutations in the AIFM1 gene associated with combined oxidative phosphorylation deficiency type 6.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area